Pleural MesotheliomaArm BArm APREDICT-Meso International Accelerator NetworkPMMeso-ORIGINS
… institutions, 16 countries) aims to define the biology driving Pleural Mesothelioma (PM). This requires assembly of a suitably characterised tissue…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 246 of 2459asthmaOCST2 biomarker guided strategy
…h patients. 1 Aims To measure outcomes of patients experiencing asthma exacerbations treated with a T2 biomarker guided strategy.Metho…
depemokimabasthmatype 2
…in the SWIFT-1/2 studies, 260 received placebo and 502 received depemokimab. Depemokimab was associated with reduced exacerbation rates ver…
asthmaBDP/FF/Gbeclomethasone dipropionateefSITTglycopyrroniumformoterol fumarate
…s and health-related outcomes of BDP/FF/G in moderate-to-severe asthma patients, previously treated with medium dose ICS+LABA or open …
COPDCOPD-specificasthmaGSKhypertensionLDND
…ents.Methods A cross-sectional online survey explored patients’ COPD experiences including symptoms and management, disease stabilit…
pneumothoraxiatrogenic pneumothoraxemphysematertiary care centre
…The most common position for the nodules in patients developing pneumothorax was RUL (n=18) followed by RLL (n=14), LLL (N=10), LUL (N=9) an…
Mepolizumabchronic obstructive pulmonary diseaseSciurbaFlynnCOPD-HELPinhaled corticosteroidsCOPDAECOPDNEJM
…Background Mepolizumab, a monoclonal antibody to interleukin-5, has been shown to redu…
brensocatibnon-cystic fibrosis bronchiectasisNCT04594369ASPENbronchiectasis
…analyses showed that, consistent with the phase 2 WILLOW trial, brensocatib treatment resulted in a dose-dependent reduction of NSP activit…
bronchiectasisTuberculosisGORDCOPDAFDepressionDiabetesChronic Renal FailureCCFCTD+2 more
… and GORD.Conclusions We found that multimorbidity is common in bronchiectasis and is significantly associated with a poorer HRQoL, more frequ…
COPDM. catarrhalisheme
…g neutrophilic inflammation and increasing exacerbation risk in COPD patients.…
cystic fibrosisfwCFCF-pregnancyelexacaftorCF-pregnanciesCFTRmivacaftortezacaftor
… Chapman S, Mackillop L. The outcome of pregnancy in women with cystic fibrosis: a UK population-based descriptive study. BJOG. 2020 Dec 16;127…
COPDPwCOPDNHSpulmonary rehabilitation
… the NHS 10-year plan, refined into four fundamental pillars of COPD care: diagnosis, information, monitoring and treatment, which p…